Diabetes drug shows promise in multiple sclerosis

	Tweet

Treatment with the diabetes drug Actos, known technically as pioglitazone, seems to reduce brain shrinkage and may have other beneficial effects in people with multiple sclerosis (MS), researchers report.

If confirmed, this drug or one in the same class might be useful as add-on treatment for people with MS, Dr. Douglas L. Feinstein told Reuters Health.

Feinstein, at the University of Illinois, Chicago, and colleagues came to this conclusion after studying 21 patients with so-called “relapsing-remitting” MS who were randomly assigned to take 30 milligrams of pioglitazone daily or an inactive “placebo”.

As reported in the Journal of Neuroimmunology, after a year, there were no significant differences between the two groups in clinical symptoms. However, MRI scans showed a significant reduction in gray matter loss and a trend toward fewer brain lesions in the active treatment group.

Feinstein noted that the class of drugs that includes pioglitazone “is currently being tested by several different labs around the world, in other neurological diseases including Alzheimer’s disease, Parkinson’s diseases, ALS, and stroke.”

He concluded, “Our findings of possible neuroprotective effects might be applicable to those other conditions.”

SOURCE: Journal of Neuroimmunology, online May 26, 2009.

RELATED STORIES:
Unconscious decisions in the brain   Obesity/diabetes could hit life expectancy - experts   Good physical function after age 40 tied to reduced risk of stroke   Chronic fatigue differs from depression   Health issues in middle age can lead to dementia   TAU computer scientists are cracking the code on the metabolism of human tissues   Potential new treatment for Huntington and Parkinson patients   Stress may cause the brain to become disconnected   Research Shows Rehabilitation Benefits of Using Nintendo Wii   Babies Born Past Term Associated With Increased Risk of Cerebral Palsy   ‘Master switch’ gene for obesity and diabetes discovered   Research reveals some of Alzheimer’s secrets

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]